Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

Lawson Research Institute of St. Joseph’s Health Care London is receiving $7.2 million in funding for studies in an emerging ...

Scanners IndustryThe global positron emission tomography (PET) scanners market is set to experience significant growth, with an estimated valuation of USD 1.3 billion in 2023 and a projected increase ...

The Alzheimer’s Association advised against diagnosing the disease on biomarkers alone, but other experts said the genie ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

A new study has found that taking longer to reach the rapid eye movement (REM) stage of sleep is linked to a greater risk of ...

The quest to advance detection and treatment of Alzheimer's disease and to personalize cancer care has received a major boost, with $7.2 million in funding to Lawson Research Institute (Lawson) of St.

A consortium of Alzheimer’s experts produced a revised set of guidelines for utilization of amyloid and tau PET imaging to detect disease-related symptomology. Image: Adobe Stock “Amyloid and ...

Taking longer to reach the rapid eye movement (REM) stage of sleep could mean you are more likely to develop dementia.

The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid ®) and blood test (PrecivityAD ®) to market, as well as fueling ...

A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...